4/A//SEC Filing
THOMPSON JOHN CRAIG 4/A
Accession 0001214659-17-005550
CIK 0001316175other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 6:56 PM ET
Size
5.0 KB
Accession
0001214659-17-005550
Insider Transaction Report
Form 4/AAmended
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Purchase
Common stock
2017-09-07$1.43/sh+10,400$14,893→ 11,298 total
Footnotes (1)
- [F1]The Reporting Person acquired the shares in the open market at an average cost of $1.432. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017. This is an amendment to correct two errors in the original form 4 filed on September 7, 2017.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001509643
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 6:56 PM ET
- Size
- 5.0 KB